Trial court erred in
Bausch Health’s Valeant had sued Mylan to prevent it from selling generic until patent expires in April 2024
- Case was remanded to trial court in New Jersey for further proceedings
- Patent expires in April 2024: FDA Orange Book
To contact the reporter on this story:
To contact the editors responsible for this story:
© 2020 Bloomberg L.P. All rights...